Navigation Links
Switzerland Posts Biotech Gains in 2009
Date:5/26/2010

NEW YORK, May 26 /PRNewswire/ -- Despite a less than favorable global economic environment the Swiss biotechnology industry performed rather well in 2009, reports Mario Brossi, North American senior advisor for Switzerland Trade and Investment Promotion.  According to the Swiss Biotech Report 2010 employment in the sector grew 6% to 19,071 while turnover reached CHF 9.3 billion*, a 7% increase over the prior year.

"The report notes that while the financing environment was challenging, Swiss companies were able to raise CHF 370 million in new capital, led by NovImmune's CHF 60 million in venture capital," Mr. Brossi said.  "BioMedInvest II raised CHF 100 million in new capital and Index Ventures EUR 350 million for early stage investment."

In other activity mondoBiotech floated its shares on the SWX Swiss Exchange, Evolva became public through a reverse merger with Arpida, and ESBATech in a transaction worth up to CHF 600 million was acquired by eye care leader Alcon.

"A measure of a country's ranking in a particular field is the number of patents filed per million of population," Mr. Brossi said.  "The World Patent Index reports that for Switzerland the number of biotech patents registered under this criterion is about 250.  This compares favorably with the U.S. (70), Japan (65), Germany (45), and Great Britain (40).  Much of the country's success in biotech is due to strong Federal support, its network of excellent research institutions and research-oriented industrial players."

According to the Swiss Biotech Report 2010 as of 2009 there were 327 biotech firms in the country, of which 65 are classified as suppliers to the industry.

Switzerland at BIO 2010

At the recently concluded BIO 2010 International Convention in Chicago, Swiss biotech was represented by 18 companies in the Swiss Pavilion and 9 pavilion partners including cantonal and regional economic development agencies, Swiss biotech clusters, the SIX Swiss Exchange, and the country's innovation promotion agency CTI.  Swiss presentations during the technical sessions covered monoclonal antibodies and white (industrial) biotechnology.  The Swiss Delegation was the 10th largest country delegation at BIO.

Further information at www.swissbiotechreport.ch

*1 Swiss Franc (CHF) = ~U.S. $0.86


'/>"/>
SOURCE Switzerland Trade and Investment Promotion
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Orameds Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the Third International Conference on Advanced Technologies and Treatments for Diabetes in Basel, Switzerland
2. Accumetrics, Inc. Announces European Distribution Channels for France, Austria, Switzerland, Netherlands, Belgium and Luxembourg
3. Webcast Alert: Oxygen Biotherapeutics, Inc. Investor Meeting in Zurich, Switzerland
4. 16th International Process Development Conference to be Held June 14-17, 2009 in Arosa, Switzerland
5. Diffusion Pharmaceuticals Announces Completion of a $2.9 Million Private Placement and Company Presentations at Upcoming Industry Conferences in Geneva, Switzerland and Naples, Florida
6. Pharmaxis Aridol Approved for Sale in Switzerland
7. 220 Companies Place Switzerland First in Biotech Density Per Capita
8. First CyberKnife System Sold in Switzerland
9. Synosia Therapeutics Appoints Chief Financial Officer to New Company Headquarters in Switzerland
10. Pharsight to Present at ROeS Seminar in Bern, Switzerland on September 10 & 11, 2007
11. OpenQ Posts a 200% Revenue Growth in the First Half of 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , ... June 23, 2016 , ... ... pleased to announce the launch of their brand, UP4™ Probiotics, into Target stores ... 35 years, is proud to add Target to its list of well-respected retailers. ...
(Date:6/23/2016)... 23, 2016 A person commits a crime, and ... to track the criminal down. An outbreak of ... Drug Administration (FDA) uses DNA evidence to track down the ... Sound far-fetched? It,s not. The FDA has increasingly used a ... of foodborne illnesses. Put as simply as possible, whole genome ...
(Date:6/23/2016)... MONICA, Calif. , June 23, 2016  The Prostate Cancer Foundation ... pioneer increasingly precise treatments and faster cures for prostate cancer. Members of the ... institutions across 15 countries. Read More About the Class ... ... ...
(Date:6/23/2016)... ... 2016 , ... Supplyframe, the Industry Network for electronics hardware ... . Located in Pasadena, Calif., the Design Lab’s mission is to bring together ... built and brought to market. , The Design Lab is Supplyframe’s physical representation ...
Breaking Biology Technology:
(Date:4/13/2016)... April 13, 2016  IMPOWER physicians supporting Medicaid patients ... a new clinical standard in telehealth thanks to a ... the higi platform, IMPOWER patients can routinely track key ... body mass index, and, when they opt in, share ... visit to a local retail location at no cost. ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
(Date:3/23/2016)... , March 23, 2016 ... Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung mit ... Inc. (NASDAQ: MESG ), ein ... dass das Unternehmen mit SpeechPro zusammenarbeitet, um ... der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im ...
Breaking Biology News(10 mins):